key: cord-0851899-tdbu799n
authors: Bignardi, P. R.; Castello, P. A.; Aquino, B. M.; Delfino, V. D. A.
title: Is the vitamin D status of patients with COVID-19 associated with reduced mortality?
date: 2021-03-26
journal: nan
DOI: 10.1101/2021.03.25.21254310
sha: c756705c2ea7ea1042d0857ca7a80eb223e18873
doc_id: 851899
cord_uid: tdbu799n

A systematic review with meta-analysis was performed to assess a possible association between plasma vitamin D levels and mortality in patients with COVID-19. PubMed, EMBASE, and Cochrane Library databases were searched. Studies involving COVID-19 patients that reported an association between plasma vitamin D levels and COVID-19 mortality published until February 5, 2020, were included. The risk ratio (RR) and confidence interval (CI) were pooled using a fixed-effects or random-effects model. A total of 11 studies that measured plasma vitamin D levels at admission were included in the meta-analysis, ten cohorts and one case-controls. Low plasma vitamin D levels (25(OH)D) in patients with COVID-19 were not associated with mortality (RR=1.35, 95%CI 0.84-1.86). Subgroup analysis by vitamin D cut-off (<20 or 25 ng/ml and <10 or 12 ng/ml) showed were not associated with mortality. When the RR in mortality analysis was calculated included four studies that did not perform adjusted analysis for confounding factors, the result was 1.43 (95% CI 1.18-1.69), suggesting that confounders may have led many observational studies to incorrectly estimate the association between vitamin D status and mortality in COVID-19 patients. Deficient vitamin D levels were not associated with a higher mortality rate in patients with COVID-19. Randomized clinical trials are needed to assess this association.

Since the first case registered in December 2019 in the city of Wuhan, Hubei Province, China, COVID-19 has spread rapidly throughout the world for presenting strong contagious and infectious characteristics [1] [2] [3] , which have caused 2,309,370 deaths until February 8 th , 2020, in 198 countries [4] .

Worldwide data from the pandemic demonstrate a mortality rate of 0.9% in patients without comorbidities, which increases progressively based on the number of comorbidities and the patients' age [5] . Studies relating vitamin D levels to Acute Vitamin D insufficiency is defined as a blood level of 25(OH)D <30 ng/mL, vitamin D deficiency is a blood level of 25(OH)D <20 ng/mL, and severe vitamin D deficiency as a blood level of 25(OH)D < 10 ng/ml [11, 12] or <12 ng/ml, according to some authors [13, 14] . Small observational studies relating vitamin D deficiency or . CC-BY-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 26, 2021. ; https://doi.org/10.1101/2021.03.25.21254310 doi: medRxiv preprint insufficiency to COVID-19 outcomes have emerged with divergent results [15] [16] [17] [18] [19] . Thus, we conducted a systematic review followed by meta-analysis to assess a possible association between plasma vitamin D levels and mortality in patients with COVID-19.

Two investigators searched MEDLINE, EMBASE, and Cochrane Library. Studies published until February 5, 2021, were included. The following search strategy was used:

(coronavirus OR "coronavirus infections" OR COVID-19 OR "severe acute respiratory syndrome coronavirus 2") AND ("vitamin D). The language of the searches was limited to English, Spanish, and Portuguese.

Two independent authors screened the studies. Disagreements were resolved through discussion among all authors. Summaries of retrieved articles were reviewed to exclude irrelevant studies, followed by reading full text for screening. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint reports, cross-sectional, animal model study, and studies that did not mention that plasma vitamin D levels were measured at admission were excluded.

Eligible studies included assessing death or disease severity in individuals with plasma vitamin D. They should provide the odds ratio (OR), risk ratio (RR), or hazard ratio (HR) with 95% confidence intervals (CI). Inclusion was not restricted by study size.

Data extracted included authors, study design, country of origin, demographic characteristics (age and sample size), COVID-19 diagnosis, outcomes relevant studies on the study question. Two independent investigators performed data extraction.

Disagreements were resolved through discussion among all authors.

The analysis focused on the mortality outcome in patients with COVID-19 within the low plasma vitamin D levels group compared with the sufficient plasma vitamin D level group. We performed one stratified analysis by cut-off vitamin D (<20 or 25 ng/ml and <10 or 12 ng/ml), and a second stratified analysis using studies that provided analysis adjusted for confounding factors and studies that did not. For the present meta-analysis, vitamin D levels were standardized to ng/ml; studies that provided vitamin D levels in nmol/l had these levels transformed into ng/ml[10]. Besides, a sensitivity analysis was performed, omitting each study to detect the influence on the overall effect's estimate. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Effect estimates with the most significant degree of adjustment for potential confounding factors were extracted. HR was considered comparable to RR. For studies that reported OR, a corrected RR was computed as already described [22] . Pooled RR and 95% confidence interval (CI) were calculated using a fixed or random-effects model according to the studies homogeneity. The Cochran Q test and the I 2 statistic were used to evaluate the statistical significance and degree of heterogeneity between the studies, respectively. The statistic I 2 ≥50% reveals substantial heterogeneity. Finally, the publication bias was examined by the Egger test and a funnel plot. All analyses were performed with Stata/SE v.14.1 software (StataCorpLP, USA). is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 

Seven-hundred and seventy-two (772) studies were identified through database research. Of these, 653 studies were duplicate articles or were excluded based on predetermined eligibility criteria during title/abstract review. According to the inclusion and exclusion criteria, we identified 11 studies[23, 24, 33, 25-32] that were eligible for this review and meta-analysis ( Fig. 1 

The mortality outcome was extracted from the 11 studies. Bennouar et al. [29] and Radujkovic et al. [26] were included twice because they analysed two cut-offs of vitamin D, <10 ng/ml and <20 ng/ml. Figure 2 shows that the mortality in patients with deficient plasma vitamin D levels did not differ from patients with sufficient plasma vitamin D levels (RR=1.35, 95%CI 0.84-1.86, I 2 =62.3%). Analysis by vitamin D level (Fig. 2) showed a RR=1.34 (95% CI 0.79-1.89, I2 = 69.6%) for studies with plasma vitamin D <20 or 25 ng/ml, and RR=1.50 (95% CI 0.02-3.02, I 2 = 2.4%) for studies with plasma vitamin D <10 or 12 ng/ml. Subgroup analysis (Fig. 3) , including studies that performed adjustments for age and at least one more confounding factor (obesity, hypertension, diabetes, chronic kidney disease, and cardiovascular disease), revealed an RR=1.49 (95% CI 0.44-2.55, I 2 = . CC-BY-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 26, 2021. ; https://doi.org/10.1101/2021.03.25.21254310 doi: medRxiv preprint 60.1%). The analysis, including studies that did not mention adjustment for confounders, showed an increased mortality risk (RR=1.43, 95%CI 1.18-1.69, I 2 =2.2%). Table 2 shows sensitivity analyses performed, excluding one study that adjusted confounding factors at a time for the mortality outcome. There was no change in Cochran`s Q test, and the I 2 varied from 24.1% to 65.0%, persisting the same results in all scenarios.

The risk of bias in studies is detailed in Table 3 . The estimated bias coefficient was 0.103, with P-value >0.05, indicating no small-study effects. A funnel plot was performed but failed to detect possible small study effects (Fig. 4) . Therefore, the tests provide weak evidence for the presence of publication bias. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 

This is the first systematic review with meta-analysis to assess only studies that measured plasma vitamin D levels in patients close to the diagnosis of COVID-19.

Observational studies have associated low plasma vitamin D levels and poor outcomes in patients with COVID-19. However, many of these studies used the plasma vitamin D level measured from a few months to years before the diagnosis of COVID-19[34, 35].

The biological variability of vitamin D is known, and its plasma levels can vary from 13 to 26% in 4 months. Plasma vitamin D can also vary with age and the appearance of

This study did not show an association between vitamin D status in COVID-19 patients and increased mortality risk. The overall analysis of mortality did not reveal an association between low plasma vitamin D levels and mortality. Likewise, the subgroup analysis with the studies that perform adjusted analysis with age and at least one more confounder did not show this association.

However, an analysis including only studies that did not performed adjusted analysis with confounders revealed an association between low plasma vitamin D levels and an increased risk of death (1.43-fold), which shows that confounding factors may have driven many previous studies results. Therefore, our meta-analysis suggests that is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint [46] [47] [48] [49] [50] [51] . Type 2 diabetes, hypertension, and cardiovascular disease also are associated with vitamin D deficiency [52, 53] .

It is known that vitamin D has a role in modulating the immune response, and its deficiency is associated with an increased risk of developing viral and bacterial infections is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint findings that plasma levels of 1,25(OH)2D were a better predictor of mortality by sepsis than Calcifediol [67] . In addition, 1,25(OH)2D antiviral action against SARS-CoV2 and other virus has been proposed [68, 69] .

This study has several strengths. To our knowledge, this is the first meta-analysis associating plasma vitamin D levels measured on or near hospital admission of patients with COVID-19, and that included studies that performed analysis adjusted with confounders. The main study limitations were analysis that has used different cut-offs of plasma vitamin D, substantial heterogeneity, and observational design of the selected studies. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 26, 2021. ; . CC-BY-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 26, 2021. ; https://doi.org/10.1101/2021.03.25.21254310 doi: medRxiv preprint

Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel

Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle

WHO | Pneumonia of unknown cause -China. WHO

Accessed 16

Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy Supplemental content

Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and metaanalysis

Obesity and vitamin D deficiency: A systematic review and meta-analysis

Vitamin D3 Distribution and status in the body

Vitamin D in obesity

Vitamin D and Aging

Vitamin D in chronic kidney disease and dialysis patients

Vitamin D and diabetes

SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule

Seasonal and age-related differences in serum 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone in patients from Western Norway

Gene-by-diet interactions affect serum 1,25-dihydroxyvitamin D levels in male BXD recombinant inbred mice

Mechanistic study of the cause of decreased blood 1,25-Dihydroxyvitamin D in sepsis

Serum active 1,25(OH) 2 D, but not inactive 25(OH)D vitamin D levels are associated with cardiometabolic and cardiovascular disease in psoriasis

Serum 1,25-Dihydroxyvitamin D: An Outcome Prognosticator in Human Sepsis

Controversial effects of vitamin d and related genes on viral infections, pathogenesis, and treatment outcomes

ALT: alanine transaminase, AST: aspartate aminotransferase, BMI: body-mass index